Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editing

被引:9
|
作者
Chen, Carol X. -Q. [1 ]
You, Zhipeng [1 ]
Abdian, Narges [1 ]
Sirois, Julien [1 ]
Shlaifer, Irina [1 ]
Tabatabaei, Mahdieh [2 ]
Boivin, Marie-Noelle [2 ]
Gaborieau, Lydiane [2 ]
Karamchandani, Jason [2 ]
Beitel, Lenore K. [1 ]
Fon, Edward A. [3 ,4 ]
Durcan, Thomas M. [1 ]
机构
[1] McGill Univ, Neuros Early Drug Discovery Unit EDDU, 3801 Univ St, Montreal, PQ H3A 2B4, Canada
[2] McGill Univ, C BIG Repository C BIG, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada
[3] Montreal Neurol Inst, Dept Neurol & Neurosurg, McGill Parkinson Program, Montreal, PQ H3A 2B4, Canada
[4] Montreal Neurol Inst, Dept Neurol & Neurosurg, Neurodegenerat Dis Grp, Montreal, PQ H3A 2B4, Canada
关键词
D O I
10.1016/j.scr.2022.102806
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Autosomal recessive mutations in either PRKN or PINK1 are associated with early-onset Parkinson's disease. The corresponding proteins, PRKN, an E3 ubiquitin ligase, and the mitochondrial serine/threonine-protein kinase PINK1 play a role in mitochondrial quality control. Using CRISPR/CAS9 technology we generated three human iPSC lines from the well characterized AIW002-02 control line. These isogenic iPSCs contain homozygous knockouts of PRKN (PRKN-KO, CBIGi001-A-1), PINK1 (PINK1-KO, CBIGi001-A-2) or both PINK1 and PRKN (PINK1-KO/PRKN-KO, CBIGi001-A-3). The knockout lines display normal karyotypes, express pluripotency markers and upon differentiation into relevant brain cells or midbrain organoids may be valuable tools to model Parkinson's disease.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Generation of FOS gene knockout lines from a human embryonic stem cell line using CRISPR/Cas9
    Li, Chunfu
    Wang, Qing
    Peng, Zhiyong
    Lin, Yuchen
    Liu, Huaying
    Yang, Xiuling
    Li, Shan
    Liu, XiaoTing
    Chen, Jingru
    STEM CELL RESEARCH, 2019, 39
  • [32] Derivation of Induced Pluripotent Stem Cells Line (RCPCMi009-A-1) with Knockout of the UBE2A Gene Using CRISPR/Cas9 Genome Editing
    E. A. Khomyakova
    A. V. Fedorenko
    A. V. Surdina
    E. A. Volovikov
    L. D. Belikova
    E. A. Zerkalenkova
    M. A. Lagarkova
    A. N. Bogomazova
    Russian Journal of Developmental Biology, 2023, 54 : 365 - 373
  • [33] Derivation of Induced Pluripotent Stem Cells Line (RCPCMi009-A-1) with Knockout of the UBE2A Gene Using CRISPR/Cas9 Genome Editing
    Khomyakova, E. A.
    Fedorenko, A. V.
    Surdina, A. V.
    Volovikov, E. A.
    Belikova, L. D.
    Zerkalenkova, E. A.
    Lagarkova, M. A.
    Bogomazova, A. N.
    RUSSIAN JOURNAL OF DEVELOPMENTAL BIOLOGY, 2023, 54 (06) : 365 - 373
  • [34] Generation of a heterozygous and a homozygous CSF1R knockout line from iPSC using CRISPR/Cas9
    Schmitz, Anne S.
    Korneck, Milena
    Raju, Janani
    Lamsfus-Calle, Andres
    Daniel-Moreno, Alberto
    Antony, Justin S.
    Mezger, Markus
    Schoels, Ludger
    Hauser, Stefan
    Hayer, Stefanie N.
    STEM CELL RESEARCH, 2023, 69
  • [35] Generation of a TRPV1 knockout human pluripotent stem cell line (WAe009-A-U) using CRISPR/Cas9
    Cao, Yuhong
    Tang, Ling
    Su, Jun
    Wang, Hao
    Liang, Ping
    Rong, Kuang
    Gong, Tingyu
    STEM CELL RESEARCH, 2023, 72
  • [36] Generation of a SMO homozygous knockout human embryonic stem cell line WAe001-A-16 by CRISPR/Cas9 editing
    Wu, Feima
    Gao, Ge
    Pan, Tingcai
    Yang, Zhen
    Xu, Guosheng
    Abbas, Nasir
    Liu, Yanli
    Chen, Yan
    Tan, Shenglin
    You, Kai
    Ke, Xinrong
    Zhuang, Yuanqi
    Lin, Xianhua
    Yang, Fan
    Li, Yin-xiong
    STEM CELL RESEARCH, 2018, 27 : 5 - 9
  • [37] Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9
    Kim, So-Jung
    Habib, Omer
    Kim, Jin-Soo
    Han, Hyo-Won
    Koo, Soo Kyung
    Kim, Jung-Hyun
    STEM CELL RESEARCH, 2017, 19 : 46 - 48
  • [38] Generation of a WWTR1 mutation induced pluripotent stem cell line, MUSIi012-A-1, using CRISPR/Cas9
    Lorthongpanich, Chanchao
    Jiamvoraphong, Nittaya
    Supakun, Prapasri
    Damkham, Nattaya
    Terbto, Papussorn
    Waeteekul, Supaporn
    U-Pratya, Yaowalak
    Laowtammathron, Chuti
    Issaragrisil, Surapol
    STEM CELL RESEARCH, 2019, 41
  • [39] Generation of two ISL1-tdTomato reporter human induced pluripotent stem cell lines using CRISPR-Cas9 genome editing
    Tsukamoto, Satomi
    Nakade, Koji
    Wakabayashi, Tamami
    Nakashima, Kenichi
    Takami, Miho
    Hemmi, Yasuko
    Kuramochi, Yuji
    Shimizu, Tomoya
    Arai, Yutaka
    Matsuo-Takasaki, Mami
    Noguchi, Michiya
    Nakamura, Yukio
    Miwa, Yoshihiro
    Hayashi, Yohei
    STEM CELL RESEARCH, 2021, 53
  • [40] CRISPR/Cas9 Genome Editing to Repair Receptor-Mediated Endocytosis in Homozygous Familial Hypercholesterolemia Induced Pluripotent Stem Cells
    Omer, Linda
    Hudson, Elizabeth A.
    Hoying, Jay B.
    Boyd, Nolan L.
    FASEB JOURNAL, 2017, 31